Utah Medical Products, Inc. $UTMD Stock Holdings Cut by Renaissance Technologies LLC

Renaissance Technologies LLC cut its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 4.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 184,114 shares of the medical instruments supplier’s stock after selling 9,500 shares during the quarter. Renaissance Technologies LLC owned 0.06% of Utah Medical Products worth $11,413,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Brandes Investment Partners LP lifted its holdings in shares of Utah Medical Products by 4.0% in the fourth quarter. Brandes Investment Partners LP now owns 351,322 shares of the medical instruments supplier’s stock valued at $19,660,000 after buying an additional 13,392 shares during the period. Quantinno Capital Management LP bought a new position in Utah Medical Products during the second quarter valued at about $608,000. Ritholtz Wealth Management grew its holdings in Utah Medical Products by 168.5% during the first quarter. Ritholtz Wealth Management now owns 14,807 shares of the medical instruments supplier’s stock worth $918,000 after acquiring an additional 9,293 shares during the period. Geode Capital Management LLC grew its holdings in Utah Medical Products by 6.5% during the second quarter. Geode Capital Management LLC now owns 114,816 shares of the medical instruments supplier’s stock worth $6,537,000 after acquiring an additional 7,040 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in Utah Medical Products by 114.9% during the fourth quarter. Goldman Sachs Group Inc. now owns 11,033 shares of the medical instruments supplier’s stock worth $617,000 after acquiring an additional 5,900 shares during the period. Institutional investors own 69.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “hold (c-)” rating on shares of Utah Medical Products in a report on Friday, May 22nd. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Utah Medical Products currently has an average rating of “Hold”.

Utah Medical Products Stock Performance

Shares of NASDAQ:UTMD opened at $70.52 on Friday. The stock has a market capitalization of $224.25 million, a price-to-earnings ratio of 21.50 and a beta of 0.36. Utah Medical Products, Inc. has a 1-year low of $53.66 and a 1-year high of $75.75. The company has a 50 day moving average price of $68.46 and a 200 day moving average price of $65.79.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Thursday, July 23rd. The medical instruments supplier reported $0.84 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 8.79% and a net margin of 29.04%.The company had revenue of $8.53 million for the quarter.

Utah Medical Products Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, July 3rd. Investors of record on Wednesday, June 17th were issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date was Wednesday, June 17th. Utah Medical Products’s payout ratio is presently 37.80%.

Utah Medical Products Company Profile

Utah Medical Products, Inc (NASDAQ: UTMD), headquartered in Midvale, Utah, is a designer, manufacturer and marketer of single‐use medical devices focusing principally on respiratory therapy and patient monitoring applications. Since its founding in the late 1970s, the company has built a reputation for innovation in airway management and non‐invasive monitoring products used in acute and long‐term care settings.

The company’s core product portfolio includes tracheostomy tubes and related accessories, endotracheal tube holders, disposable catheters and sensors for measuring end‐tidal carbon dioxide (CO₂).